Skip to Main Content

Aquestive Therapeutics, Inc. Common Stock

AQST Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
AQST Income Statement
AQST Balance Sheet
AQST Cash Flow

Recent trades of AQST by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
AQST Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
AQST Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
AQST Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by AQST's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Enhanced delivery epinephrine compositions Jul. 02, 2024
  • Patent Title: System and method for making personalized individual unit doses containing pharmaceutical actives Nov. 07, 2023
  • Patent Title: Oral film compositions and dosage forms having precise active dissolution profiles Jan. 03, 2023
  • Patent Title: Pharmaceutical compositions with enhanced permeation Mar. 15, 2022
  • Patent Title: Process for manufacturing a resulting pharmaceutical film Dec. 28, 2021
  • Patent Title: Enhanced delivery epinephrine compositions Dec. 07, 2021
  • Patent Title: Enhanced delivery epinephrine compositions Nov. 02, 2021
  • Patent Title: Dual lane coating Sep. 28, 2021
  • Patent Title: Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions Aug. 03, 2021
  • Patent Title: Reduction in stress cracking of films Mar. 16, 2021
  • Patent Title: Manufacturing of small film strips Mar. 09, 2021
  • Patent Title: Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom Jan. 12, 2021
  • Patent Title: Sublingual and buccal film compositions Nov. 03, 2020
  • Patent Title: Process for manufacturing a resulting pharmaceutical film Aug. 04, 2020
  • Patent Title: Reduction in stress cracking of films Nov. 05, 2019
  • Patent Title: Manufacturing of small film strips Apr. 30, 2019
  • Patent Title: Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom Oct. 30, 2018
  • Patent Title: Sublingual and buccal film compositions Jul. 31, 2018
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of AQST in WallStreetBets Daily Discussion

AQST News

Recent insights relating to AQST

CNBC Recommendations

Recent picks made for AQST stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in AQST

AQST Top Shareholders
Shareholder
Shares Held
AQST Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

AQST Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view AQST Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top